Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Altogether 117 patients with advanced breast cancer were treated with either tamoxifen 10 mg by mouth twice daily or aminoglutethimide 250 mg by mouth four times daily with hydrocortisone 20 mg twice daily in a randomised cross-over trial in which patients who failed to respond to the first treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Smith, I E, Harris, A L, Morgan, M, Ford, H T, Gazet, J C, Harmer, C L, White, H, Parsons, C A, Villardo, A, Walsh, G, McKinna, J A
Format: Artigo
Language:Inglês
Published: 1981
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1507612/
https://ncbi.nlm.nih.gov/pubmed/6797571
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items